β³ Fetching live dividend data...
Home βΊ Calculator βΊ LNDZF Dividend Calculator 2026
Evome Medical Technologies Inc. Β· OTC
Price: $0.00 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in LNDZF β $3.2184067729444594e+27M in 10 years Β· $255,137,523,223,019,660,000,000,000,000,000.00/month
Evome Medical Technologies Inc. is a global company that conceives, produces, and markets medical equipment across the Americas and other international markets. The firm's diverse array of products is primarily focused on pain alleviation and physical restoration therapies. This broad selection includes specialized instruments like dynamometers for measuring muscle strength, advanced systems for gait training, tools for balance evaluation and re-establishment, electrical stimulation devices (both neuromuscular and transcutaneous), ultrasonic therapeutic equipment, and cutting-edge wearable technologies. All these innovations are designed to bolster human health by assisting in preventative care, therapeutic interventions, and rehabilitation efforts.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open LNDZF position with:
Real after-tax yield depends on where you live and how you hold LNDZF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 1700000.00% | 1699997.20% | $170,000,000 / yr |
| πΊπΈ US Taxable (20%) | 20% | 1600000.00% | 1599997.20% | $160,000,000 / yr |
| π¬π§ UK ISA | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| π¬π§ UK Taxable | 8.75% | 1825000.00% | 1824997.20% | $182,500,000 / yr |
| π¨π¦ TFSA | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| π¨π¦ CA Taxable | 25% | 1500000.00% | 1499997.20% | $150,000,000 / yr |
| π¦πΊ Super (pension) | 15% | 1700000.00% | 1699997.20% | $170,000,000 / yr |
| π¦πΊ AU Taxable | 30% | 1400000.00% | 1399997.20% | $140,000,000 / yr |
| π©πͺ DE Taxable | 26.375% | 1472500.00% | 1472497.20% | $147,250,000 / yr |
| π«π· FR Taxable | 30% | 1400000.00% | 1399997.20% | $140,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
LNDZF pays quarterly β 4 times per year. Next ex-div: TBD.
How LNDZF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for LNDZF sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2021-07-07 | 250,000 | $1.39 | $347.5K | ||
| Buy | 2021-06-10 | 25,000 | $0.62 | $15.5K | ||
| Buy | 2021-06-09 | 50,000 | $0.50 | $25.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the LNDZF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Evome Medical Technologies Inc. (LNDZF) is currently trading at $0.00, trading near its 52-week low. The current dividend yield is 2000000.00% based on an annual payout of $2.00 per share.
Evome Medical Technologies Inc. (LNDZF) is a healthcare stock currently trading at $0.00 with a dividend yield of 2000000.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review βIf DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
β±οΈ Takes 30 seconds Β· No signup Β· Free forever